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CC BY-NC-ND license (http://creativeBackground: The hepatitis B virus (HBV) pre-X gene resides upstream of the HBV X gene, and
together they form the HBV whole-X gene. Although it has been evident that the HBV whole-X
protein is involved in the development of hepatocellular carcinoma, its biological role and mo-
lecular mechanism remain largely unknown.
Methods: In this study, we subcloned the HBV whole-X gene and constructed a HBV whole-X
expressing vector. After transfection of the HBV whole-X gene into HL-7702 cells, the profile
of the differential cellular protein composition in the cells was analyzed by using two-
dimensional electrophoresis coupled to matrix-assisted laser desorption/ionization-time of
flight mass spectrometry.
Results: The results showed that 18 major proteins were differentially expressed in the cells
transfected with or without the HBV whole-X gene. The expression of these genes was further
confirmed by reverse transcription-polymerase chain reaction and Western blot analysis.
Conclusion: Our findings provide a new insight into the investigation of the pathological role
that the HBV whole-X gene plays in the development of hepatocellular carcinoma and may lead
to the design of novel strategies for the treatment of this disease.
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Hepatitis B virus (HBV) infection may cause a chronic liver
inflammation leading to an increased risk of liver cirrhosis
and hepatocellular carcinoma (HCC).1 The HBV DNA
genome is partially double-stranded DNA, which is about
3200 bp long and contains four open reading frames (ORFs),
the core (C), the surface (S), the polymerase (P), and the X
gene.2 The smallest X-ORF encodes the HBV X protein
(HBx), which has transactivating functions and plays a
crucial role in the development of HBV-associated HCC
through interaction with host factors. Most studies have
focused on the effective mechanism of the HBx protein in
the pathology of HCC.3,4 However, Loncarevic et al5,6
cloned a replication competent of the HBV full-length
genome in 1990 and found the presence of pre-X ORF
before the X DNA region. Later, Takahashi et al7,8 also re-
ported the presence of pre-X ORF, which is 56 nucleotide
triplets upstream of the promoter of X gene, and showed
that the pre-X ORF was detected in 50% (19/38) of HBV DNA
isolated from 40 HCC patients. Dong and colleagues9,10
revealed that the pre-X gene and the X gene could be
translated together and further characterized its tran-
scriptional activity.
The whole-X gene, including the 168-bp pre-X and the
465-bp X genes, encodes the whole-X protein composed by
210 amino acids. Studies show that the pre-X gene is pop-
ular and well conserved in HBV genomes only when the start
codon ATG is replaced by ACG (1205C / T), a missense
mutation, resulting in the disruption of the pre-X gene
translation. The information of the pre-X gene sequences is
mainly generated from the samples of patients with HCC,
chronic hepatitis, or acute fulminant hepatitis.11 It has
been reported that the whole-X protein binds with hepa-
tocellular proteins in the yeast two-hybrid assay, indicating
that the whole-X protein may play a role in regulating the
signal transduction pathways in the hepatocytes through
proteineprotein interaction, which contributes to the
pathogenesis of HCC.12 However, the physiological role of
the HBV whole-X gene remains largely unknown. In this
study, we cloned the HBV whole-X gene and analyzed the
altered protein expression profile in the cells with or
without the whole-X gene by two-dimensional electropho-
resis (2-DE) combined to matrix-assisted laser desorption/
ionization-time of flight (MALDI-TOF)/TOF mass spectrom-
etry (MS) analyses. To our knowledge, this is the first report
about the global protein changes caused by the whole-X
gene until now. Thus, the information gained herein may
provide new information on how the whole-X gene partic-
ipates in the pathogenesis of HBV-related HCC.Methods
Cloning of HBV whole-X DNA and construction of
plasmids
HBV DNA was extracted from the serum of patients with
chronic hepatitis B using the phenolechloroform extracting
method. The HBV whole-X and X genes were amplified by
polymerase chain reaction (PCR) using the correspondingprimers as shown in Table 1, and then cloned into the
pGEM-T vector. The full-length amplified whole-X gene and
X gene were confirmed by DNA sequencing and subcloned
into the pCMV-Tag2A vectors using EcoRI and XhoI digestion
to construct pCMV-Tag2A-whole X and pCMV-Tag2A-X
expression plasmids. The recombants were verified by re-
striction enzyme digestion and DNA sequencing assays.
Cell culture and transfection
HL-7702 cells were cultured in Dulbecco’s modified Eagle’s
medium high glucose (Gibco, Carlsbad, CA, USA) supple-
mented with 10% fetal bovine serum (Hyclone, Logan, UT,
USA). When the cells were grown to 90% confluence,
transfected with the recombinant plasmids pCMV-Tag2A-
whole X and pCMV-Tag2A-X, respectively, using Lipofect-
amine 2000 (Invitrogen, Carlsbad, CA, USA) according to the
instructions of the manufacturer. Empty vector pCMV-
Tag2A and pEGFP plasmids were also transfected into the
cells as controls.
2-DE
The cells were harvested 48 hours after transfection, and the
total cellular proteins were extracted by using the Ready-
Prep protein extraction kit (Bio-Rad, Hercules, CA, USA).
Briefly, the harvested cells were incubated on ice and soni-
cated for six cycles (each cycle included 6 seconds of soni-
cation and a 10-second break), then centrifuged at
17,000 rpm (26,494g) for 40minutes; next, the supernatant
was collected and cleaned up using the 2-D Clean Up kit (Bio-
Rad) to remove the salt and impurities. The concentration of
the total protein was quantified using the Bradford assay kit
(Bio-Rad). The samples (0.4mg protein per gel) were applied
to 17 cm pH 3e10 nonlinear immobilized pH gradient (IPG)
strips (Bio-Rad) by in-gel rehydration for 12 hours; then the
rehydrated strips were focused as follows: 250 V for 1 hour;
1000 V for 1 hour; 10,000 V for 5 hours, and 10,000 V until
60,000 V/hour. After equilibration, 2-DE was carried out in
12% sodium dodecyl sulfate-polyacrylamide gel electropho-
resis gel (18 cm  20 cm  1 mm) with 30 mA constant cur-
rent. A modified silver staining method was used to stain the
gels,13 then the gels were scanned with a Bio-Rad GS-800
scanner. Next, the images were analyzed with the PDQuest
software Version 6.1 (Bio-Rad) to compare the data between
the gels of the transfected cells with or without the HBV
whole-X gene. Each sample was processed three times to
minimize experimental variations. Protein spots that showed
reproducibly detected and significant differences of more
than 2-folds (p< 0.05) in all three separate gels were picked
out for the next MS analysis.
In-gel digestion
Silver-stained protein spots with significant intensity dif-
ference were cut from the 2-D gels, destained in 30 mM
potassium ferricyanide and 100 mM sodium thiosulfate (1:1
v/v) for 20 minutes, and then washed with Milli-Q water.
The destained spots were lyophilized after incubating in
0.2 M NH4HCO3 for 20 minutes. Each lyophilized protein
spot was digested with 12.5 ng/mL trypsin in 25 mM
Table 1 The information of primers and PCR condition used in this study
Oligo name Sequence (50 to 30) Annealing temperature (C) Expected length (bp)
HBV whole-X gene Fa: CCAAGTGTTTGCTGACGCAACC
Fb: GGAATTCCATGGGGCTTGGCTATTGG
58a
56b
630
R: CCCTCGAGGGTTAGGCAGAGGTGAAAAAG
HBV X gene F: GGAATTCCATGGCTGCTAGGCTGTGCTG 65 465
R: CCCTCGAGGGTTAGGCAGAGGGGAAAAAG
RKIP F: GAATAGACCCACCAGCAT 53 236
R: CGTAAACCAGCCAGACAT
KHSRP F: GCACGGTTAGGAAAGCACAT 56 153
R: TCCCTGTAGTTTTGAAGCGG
PSMB4 F: CGTATATGCGAGTCAACGACA 54 330
R: AAGCAGAGGCTGAGCCAAGA
PDCD5 F: AGTAAGCCAACAAACAGAAAAGA 54 129
R: CCTAGACTTGTTCCGTTAAGTTC
b-Actin F: AGGCCAACCGCGAAGATGACC 55 350
R: GAAGTCCAGGGCGACGTAGCAC
a To amplify the HBV whole-X gene from HBV DNA extracted from serum of patients with chronic hepatitis B.
b To amplify the HBV whole-X gene from pGEM-Tewhole X vector.
HBV Z hepatitis B virus; PCR Z polymerase chain reaction.
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the digested samples and dried the extracts by the vacuum
centrifuge method.
MALDI-TOF/TOF MS analysis
All samples obtained from lyophilized trypsin peptides
dried by a vacuum centrifuge and resuspended in 2 mL of
20% acetonitrile. The peptides were spotted on stainless-
steel sample target plate and then subjected to 4800 Plus
MALDI TOF/TOF Analyzer (Applied Biosystems, Foster City,
CA, USA) equipped with a Nd:YAG laser (355 nm). Mass
spectra for each peptide were obtained using an estab-
lished setting as described previously.14 The spectra were
analyzed with the GPS-Explorer Software 3.6 (Applied Bio-
systems) and submitted to search the NCBI database to
match the MS and MS/MS queries using the MASCOT search
engine 2.2 (Matrix Science, Boston, MA, USA).
RNA extraction and reverse transcription-PCR
Total cellular RNAs were extracted from the cells after
being transfected for 48 hours with recombinant plasmids
by TRIzol reagent (Invitrogen). The expression of RKIP,
KHSRP, PSMB4, and PDCD5 genes was determined with
reverse transcription (RT)-PCR using PrimeScript RT-PCR Kit
(Takara Bio Inc, Tokyo, Japan) according to the manufac-
turer’s instructions. The primer pairs are shown in Table 1.
Western blot analysis
The cells were collected 48 hours after transfection. Cell
proteins were extracted using the whole-cell extraction
buffer [50 mM TriseHCl (pH 8), 2 mM ethylene glycol tet-
raacetic acid, 0.2 mM EDTA, 280 mM NaCl, 10% glycerol, and
0.5% NP-40] and quantified using the DC protein assay kit
(Bio-Rad). Equal amounts of extracted proteins were run in12% sodium dodecyl sulfate-polyacrylamide gel electro-
phoresis gels, and then transferred to PVDF membranes
(Millipore, Boston, MA, USA). Next, the membranes were
blocked with 5% bovine serum albumin/ tris-buffered saline
(BSA/TBS) for 1 hour and incubated overnight with a pri-
mary antibody at 4C. For detection of RKIP (Raf-1 kinase
inhibitory protein), KHSRP (KH-splicing regulatory protein),
PSMB4 (proteasome subunit beta type 4), and PDCD5 (pro-
grammed cell death 5) expression, polyclonal rabbit anti-
RKIP antibody (1:1000; Abcam, Cambridge, MA, USA),
monoclonal mouse anti-KHSRP antibody (1:500; Abcam),
monoclonal mouse anti-Proteasome subunit beta type 4
antibody (1:500; Abcam), and polyclonal rabbit anti-PDCD5
antibody (1:1000; Abcam) were used. Antimouse or anti-
rabbit Immunoglobulin G/Horseradish Peroxidase (Abcam)
was used as secondary antibodies at 1:2000 dilutions.
Results
Construction of the HBV whole-X gene and the HBV
X gene plasmids
The HBV whole-X genes and the HBV X genes were cloned,
respectively, from the HBV DNA of chronic hepatitis B pa-
tients using a PCR cloning method. The cloned two DNA
fragments (630 bp and 465 bp in size) were sequenced, and
the sequences were confirmed to be identical to the HBV
whole-X and X genes in the GenBank through a nucleotide
blast analysis. The HBV whole-X and X genes were subcloned
into pCMV-Tag2A using EcoRI and XhoI as shown in Fig. 1.
Expression of HBV whole-X gene in transfected cells
After transfection, the expression of the HBV whole-X and
HBX genes was analyzed by RT-PCR and Western blot.
Obviously, both genes were highly expressed in the trans-
fected cells (Fig. 2A and B). To determine the transfection
338 Y. Zhang et al.efficiency, a plasmid with pEGFP was cotransfected with
the HBV whole-X and HBX gene constructs into the cells.
The result indicated that the transfection efficiency was
>90% (Fig. 2C).
Protein profile in the cells with or without the HBV
whole-X gene
The HBV whole-X gene and its function in the pathogenesis
of HCC are largely unknown. We performed proteomic
analysis to examine the expression of differential proteins
in the transfected cells with or without the HBV whole-X
gene. The cell extracts were fractionated by 2-DE, and the
gels were subjected to silver staining (Fig. 3). After a
comparison analysis using the PDQuest software (Bio-Rad),
29 protein spots with the alternation of density of more
than two-fold (p < 0.05) from the HBV whole-X protein
expressed cells were selected as significantly different
candidate proteins for subsequent MALDI-TOF/TOF MS.
Among the 29 samples, the identity of 18 proteins was
successfully determined using this method. As listed in
Table 2, the expression of 10 proteins was upregulated,
whereas the expression of the other eight proteins was
downregulated in the HBV whole-X gene expressed cells.
Interestingly, these proteins are involved in diversiform
processes of cell biology including apoptosis, signal trans-
duction, and cell proliferation. For example, FK506-binding
protein 3(FKBP3) is a novel regulator associated with the
p53 signal pathway, and can induce the degradation of
mouse double minute 2 (MDM2), leading to the activation of
p53.15 PDCD5 is an apoptosis-related gene with potent
antitumor effects.16 The RKIP may regulate many kinds of
important signaling pathways. Specifically, RKIP inhibits the
Ras-Raf-1-MEK1/2-ERK1/2 pathway through binding to Raf-Figure 1. Verification of the recombinant plasmids by re-
striction enzyme digestion.1 kinase. KHSRP has four KH-DNA binding domains respon-
sible for binding to the FUSE sequence with great affinity
and participates in the transcriptional activity of c-myc.
Our data suggest that the HBV whole-X may promote the
development of liver cancer by downregulating the
expression of RKIP, an inhibitor of the Ras-Raf-1-MEK1/2-
ERK1/2 pathway, and upregulating the expression of
KHSRP, which is associated with the activity of c-myc, a
well-known oncogene, in addition to suppressing apoptosis
by inhibiting the expression of FKBP3 and PDCD5.
We also noted that PSMB4 was found significantly upre-
gulated in whole-X and X gene transfected cells as shown in
Fig. 4. PSMB4 has various proteolytic activities, and
involved in the process of DNA repair and splicing, angio-
genesis, apoptosis, and the removal of abnormal or
damaged proteins in cells.Validation of identified proteins
To validate the results from 2-DE and MS, the differential
expression of the proteins in the cells with or without the
HBV whole-X and HBV X genes was determined using RT-PCR
and Western blot. As shown in Fig. 5A and B, the expressing
level of RKIP and PDCD5 was downregulated, whereas
KHSRP and PSMB4 expressions were upregulated in cells
transfected with the HBV whole-X, which is consistent with
the results of the proteomic analysis.
Intriguingly, although the RKIP expression was reduced in
the cells transfected with either the HBV whole-X or the
HBV X gene compared to that in the control cells, its level in
the cells with the HBV X gene was significantly decreased
compared to the HBV whole-X cells. However, the expres-
sion of KHSRP and PSMB4 was dramatically increased in the
cells transfected with either of the whole-X cells and HBV X
genes. The physiological significance of the altered
expression of these proteins in the cells with either the HBV
whole-X or the HBV X gene remains to be further
investigated.Discussion
It has been well documented that chronic HBV infection
may lead to severe liver disease including fulminant hepa-
titis, liver cirrhosis, and HCC. HBV DNA integrates into the
chromosomal genome of human hepatocytes, which is
recognized to play a crucial role in the pathogenesis of the
HCC.17 The mechanisms by which HBV leads to hepatocyte
malignant transformation is not clear. Although a line of
existing evidence suggests a pathogenetic role for the HBx
protein produced from the HBV X gene, studies have
revealed the existence of a HBV pre-X gene that may
contribute to the development of HBV-related acute
fulminant hepatitis and HCC. The HBV pre-X and HBV X
genes are combined to form the whole-X gene whose roles
are not clear in HBV infectious diseases. In this study, we
systematically analyzed the profiles of the differential
cellular protein expression in the cells with or without the
whole-X genes, and identified several targeting molecules
of the gene in the cells by using 2-D gels, followed by MS
analysis. The present study is the first to screen
Figure 2. Expression of hepatitis B virus (HBV) whole-X and X gene in transfected cells. HL-7702 cells were transfected with
pCMV-Tag2A, pCMV-Tag2A-X, and pCMV-Tag2A-whole X plasmids. (A) The transcriptional level of the genes expression were
analyzed by reverse transcription-polymerase chain reaction (RT-PCR). (B) The protein level of expression was analyzed by Western
blot. (C) pEGFP was used to check transfection efficiency (200).
Figure 3. Representative 2-DE gel images in transfected cells with recombinants. Total protein extracts from the cells with
pCMV-Tag2A (left) and whole-X (right) recombinants, were separated in the first dimension in IPG strips, then in the second
dimension by 12% SDS-PAGE and stained using the silver stain method. Differentially density of protein spots that were identified by
MS is indicated with circles. Information on 18 spots identified successfully by mass spectrometry is listed in Table 2. 2-DEZ two-
dimensional electrophoresis; IPG Z immobilized pH gradient; SDS-PAGE Z sodium dodecyl sulfate-polyacrylamide gel
electrophoresis.
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gene using comparative proteomic approaches.
The differential expression of a total of 18 proteins was
found in the cells after overexpression of the whole-X gene.
It is not surprising that these proteins are involved in
apoptosis, signaling transduction, and protein turnover. The
expression of FKBP3 and PDCD5, both of which are involved
in the p53 pathway, was downregulated in the cells trans-
fected with the whole-X gene, suggesting that suppression
of apoptosis in liver cells may contribute to thepathogenesis of liver cancer. Indeed, studies have revealed
that FKBP3 is a nuclear DNA-binding protein with a pepti-
dylprolyl cisetrans isomerase activity,18 and knock-down of
endogenous FKBP3 increases the level of MDM2, leading to
reductions of p53 and its downstream effectors p21.15 It has
been believed that PDCD5 is a positive regulator in the p53
pathway by interacting with p53.19 A decrease in PDCD5
production is overtly able to reduce the activity of p53,
resulting in the suppression of apoptosis, which promotes
tumor progression. It has been reported that PDCD5 also
Table 2 List of identified increased or decreased proteins in the HBV whole-X gene expressed cells
Accession
no.
Protein description Gene name Function Theoretical
Mr/pI
No. of
matched
peptides
Protein
Score
Coverage
(%)
Alteration
gij4503727 Peptidyl-prolyl cis
etrans isomerase
FKBP3
FKBP3 Protein folding 25,218.3/9.29 10 184 36 3.06Y
gij4505621 Raf kinase inhibitory
protein
RKIP Signal transduction 21,157.7/7.01 11 327 63 2.98Y
gij4759224 Programmed cell
death protein 5
PDCD5 Apoptosis 14,276.3/5.77 7 137 57 2.85Y
gij157412270 Heterogeneous
nuclear
ribonucleoprotein M
HNRNPM mRNA splicing 73,857.5/8.94 35 668 46 2.56Y
gij7542837 Medium-chain acyl-
CoA dehydrogenase
ACADM Lipid metabolism 47,014.8/8.61 16 362 32 2.41Y
gij1100209 Transcription factor
ZFM1
SF1 Transcription
regulation
62,220.1/9.4 8 93 39 2.36Y
gij13937981 Peptidylprolyl
isomerase A
PPIA Regulation of viral
genome replication
18,228/7.68 7 201 54 2.08Y
gij5031777 Isocitrate
dehydrogenase (NAD)
subunit alpha
IDH3A Binding 40,022.2/6.47 9 183 26 2.06Y
gij54648253 KHSRP protein KHSRP Transcription
regulation
73,307.5/8 27 753 45 2.93[
gij48145757 Proteasome subunit
beta type-4
PSMB4 Apoptosis 29,228.5/5.7 10 368 46 2.83[
gij4507645 Triosephosphate
isomerase isoform 1
TPI1 Metabolism 26,937.8/6.45 18 489 67 2.79[
gij55664661 Voltage-dependent
anion channel 2
VDAC2 Binding 30,842.1/8 11 312 50 2.68[
gij23308577 D-3-Phosphoglycerate
dehydrogenase
PHGDH Metabolism 57,355.7/6.29 19 529 41 2.63[
gij45767717 Histone cluster 1,
H2bm
HIST1H2BM Binding 14,079.7/10.39 8 143 58 2.57[
gij4502549 Calmodulin Calm1 Receptor binding 16,826.8/4.09 2 125 25 2.44[
gij23308751 3-Hydroxyisobutyrate
dehydrogenase
HIBADH Metabolism 35,704.9/8.38 4 94 20 2.39[
gij2204207 Glutathione S-
transferase
GST Metabolism 23,595.1/5.43 7 361 48 2.28[
gij31645 Glyceraldehyde-3-
phosphate
dehydrogenase
GAPC Binding 36,202.4/8.26 16 422 52 2.12[
HBV Z hepatitis B virus.
340 Y. Zhang et al.induces cell apoptosis via inhibiting the Ras/Raf/MEK/ERK
signaling pathway.20 Downregulation of PDCD5 expression
has been found in several types of human tumors, and
changing of the protein level is used for the prognosis of
cancer progression.21e24 It has been well established that
RKIP inhibits the MAPK pathway by disrupting the interac-
tion between the Raf-1 and MEK the upstream components
of ERK.25,26 The activation of the Ras/Raf/MEK/ERK
signaling pathway is associated with many kinds of human
cancers, for example, breast cancer and renal cell
carcinoma.27,28 Studies have shown that RKIP mRNA and
protein were downregulated in HCC.29,30 As a result, this
leads to the constitutive activation of the ERK/MAPK
pathway in HCC tumors. Furthermore, RKIP was also
found to be downregulated during HBx-mediatedhepatocarcinogenesis.31,32 It is possible that the function
of the HBV whole-X in hepatocytes is to suppress apoptosis
and promote cell proliferation, which leads to the devel-
opment of HCC; however, further investigation is necessary
to evaluate the results.
PSMB4 is involved in the proteasome pathway. Studies
have linked the proteasomal proteins to tumorigenesis. The
previous studies proved that the ubiquitineproteasome
pathway plays a crucial role in intracellular protein degra-
dation, such as cell cycle regulatory proteins. An increased
level of proteasomal proteins was found in leukemia cells33
and samples from patients with renal carcinoma34 and
breast cancer.35 Evidence has shown that the proteasome is
a possible cellular target of HBx.36 HBx interacts with the
subunits of proteasome,37e39 impacting hepadnavirus
Figure 4. Analysis of the proteins of interest. Protein extracts from the whole-X cells and control were compared in two-
dimensional electrophoresis (2-DE) gel. The proteins of interest are selected and circled. The histograms of expression kinetics
are shown on the right.
Figure 5. Verification of 2-DE results by RT-PCR and Western blot. (A) In RT-PCR analysis, the mRNA expressions of four proteins
were analyzed in vector control cells (1), HBx cells (2), and whole X cells (3). (B) Western blot assay identified differential proteins
in transfected HL-7702 cells with different plasmids. b-Actin is included as an internal control. 2-DE Z two-dimensional elec-
trophoresis; HBx Z HBV X protein; SDS-PAGE Z sodium dodecyl sulfate-polyacrylamide gel electrophoresis.
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342 Y. Zhang et al.replication.40 Our data revealed that PSMB4 in the cells
overexpressing the HBV whole-X and HBx gene is signifi-
cantly upregulated, suggesting that HBV infection promot-
ing the pathogenesis of HCC may be through accelerating
protein turnover as well.
Taken together, our results provide new insight into the
investigation of molecular mechanism by which the HBV
whole-X gene contributes to the development of HCC. The
information may be useful for the design of therapeutic
strategies for HCC and other liver diseases caused by HBV
infection.
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